X-153930109-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_003491.4(NAA10):c.586G>A(p.Glu196Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000108 in 1,208,804 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003491.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAA10 | NM_003491.4 | c.586G>A | p.Glu196Lys | missense_variant | 8/8 | ENST00000464845.6 | NP_003482.1 | |
NAA10 | NM_001256120.2 | c.568G>A | p.Glu190Lys | missense_variant | 8/8 | NP_001243049.1 | ||
NAA10 | NM_001256119.2 | c.541G>A | p.Glu181Lys | missense_variant | 7/7 | NP_001243048.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAA10 | ENST00000464845.6 | c.586G>A | p.Glu196Lys | missense_variant | 8/8 | 1 | NM_003491.4 | ENSP00000417763 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000903 AC: 1AN: 110785Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 32961
GnomAD4 exome AF: 0.0000109 AC: 12AN: 1098019Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 5AN XY: 363381
GnomAD4 genome AF: 0.00000903 AC: 1AN: 110785Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 32961
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2022 | The c.586G>A (p.E196K) alteration is located in exon 8 (coding exon 8) of the NAA10 gene. This alteration results from a G to A substitution at nucleotide position 586, causing the glutamic acid (E) at amino acid position 196 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at